| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 36.194 | 39.620 | 46.807 | 57.020 | 53.652 | 60.617 | 51.157 | 55.493 | 110.265 |
| Total Income - EUR | - | 36.870 | 40.117 | 47.736 | 58.678 | 56.422 | 61.007 | 54.071 | 60.905 | 120.955 |
| Total Expenses - EUR | - | 30.080 | 39.620 | 56.326 | 61.786 | 66.874 | 63.979 | 48.188 | 73.199 | 111.765 |
| Gross Profit/Loss - EUR | - | 6.791 | 497 | -8.590 | -3.108 | -10.452 | -2.972 | 5.882 | -12.295 | 9.190 |
| Net Profit/Loss - EUR | - | 6.424 | 92 | -9.068 | -3.697 | -10.994 | -3.621 | 5.350 | -12.729 | 7.779 |
| Employees | - | 0 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - Flavet Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 961 | 843 | 827 | 521 | 395 | 7.483 | 20.312 |
| Current Assets | - | 11.188 | 15.504 | 7.233 | 8.918 | 2.872 | 3.906 | 11.835 | 17.423 | 17.938 |
| Inventories | - | 2.177 | 8.159 | 6.857 | 8.789 | 2.766 | 2.950 | 11.775 | 15.940 | 14.443 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 198 |
| Cash | - | 9.011 | 7.346 | 375 | 130 | 107 | 956 | 60 | 1.483 | 3.297 |
| Shareholders Funds | - | 6.469 | 6.451 | -2.735 | -6.379 | -17.252 | -20.650 | -15.363 | -28.045 | -20.110 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.719 | 9.053 | 10.929 | 16.140 | 20.951 | 25.077 | 27.593 | 52.951 | 58.360 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Flavet Med S.r.l.